ArticleThe Lancet regional health. Europe2026
Comparative Effectiveness and Safety of Once-Weekly Injectable Semaglutide Versus Dulaglutide in Individuals with Type 2 Diabetes Managed in UK Primary Care: A Population-Based Cohort Study.
Franziska S Ulrich et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.